Cargando…
VHHs as tools for therapeutic protein delivery to the central nervous system
BACKGROUND: The blood brain barrier (BBB) limits the therapeutic perspective for central nervous system (CNS) disorders. Previously we found an anti-mouse transferrin receptor (TfR) VHH (Nb62) that was able to deliver a biologically active neuropeptide into the CNS in mice. Here, we aimed to test it...
Autores principales: | Wouters, Yessica, Jaspers, Tom, Rué, Laura, Serneels, Lutgarde, De Strooper, Bart, Dewilde, Maarten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531356/ https://www.ncbi.nlm.nih.gov/pubmed/36192747 http://dx.doi.org/10.1186/s12987-022-00374-4 |
Ejemplares similares
-
Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies for Brain Delivery of Biologics
por: Rué, Laura, et al.
Publicado: (2023) -
Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer’s disease
por: Serneels, Lutgarde, et al.
Publicado: (2020) -
The composition of the γ-secretase complex defines its Aβ product profile
por: Acx, Hermien, et al.
Publicado: (2013) -
Identification and in vivo characterization of a brain-penetrating nanobody
por: Wouters, Y, et al.
Publicado: (2020) -
Intracellular VHHs to monitor and modulate GPCR signaling
por: Raynaud, Pauline, et al.
Publicado: (2022)